ProstaSol contains a proprietary mix of lignans from flaxseed; curcuminoids from turmeric root and various plant derived sterols – all exerting beneficial effects in prostate ailments.
Directions: Take 3×3 tablets per day, preferably on an empty stomach half an hour before a meal (3 before breakfast, 3 before lunch and 3 before dinner), until PSA-level NADIR is reached. Continue to take 3×3 for about 2 months even when NADIR is reached and then start reducing ProstaSol dosage step-by-step slowly while checking PSA levels every month. Dr. Pfeifer usually reduces ProstaSol dosage from 9 to 8 capsules per day and then stays at this level for one month, and then reduces to 7 per day and stays at that level for 1 month. The PSA should be checked monthly. Often, ProstaSol can be reduced to a maintenance dose of about 1-2 capsules per day with stable PSA levels. Remember, however, that each patient is different. More detailed product description
Please note that Medpro’s ProstaSol should not be confused with the product sold in the US under the same name. Medpro’s ProstaSol contains a few additional ingredients to make it more effective, and is manufactured exclusively in the Netherlands, Europe using ingredients regulated by the Dutch ministry of Health. Medpro’s ProstaSol is made under HACCP, GMP and GNP, and none of its ingredients are tainted with synthetic oestrogens.
BioBran™ is a natural food extract, made from “pre-digested” rice bran using enzymes from Shitake mushrooms. It is a powerful immune booster which works by stimulating the activity of T and B cells and particularly natural killer cells which form the front line of defence of our immune system. There are over 15 published studies in scientific journals which show that BioBran is one of the most effective and safe immunomodulators available for immune-compromised individuals.
Directions: 1 or 2 x 1000mg sachets of BioBran daily (ideally 20 minutes after a meal dissolved in a little water). If you start with 2 sachets per day, this can be reduced to 1 sachet by the end of Treatment. More detailed product description
IMUPROS™: is a blend of nutritional supplements, formulated with vitamins, trace elements, ginseng, lycopene and green tea extract for optimum prostate function.
Directions: 2 or 3 tablets per day with meals. Dr. Pfeifer generally does not reduce the dosage of this supplement during his protocol. More detailed product description
Curcumin combi extra forte™: This extract from the turmeric spice contains the potent anti-inflammatory and antioxidant compound curcumin, plus resveratrol — a plant compound from red grapes with strong antioxidant benefits and black pepper to enhance their absorption.
Directions: 3 x capsules a day with meals. Again, the dosage is not reduced during protocol.
Should you feel nausea taking the ProstaSol, you can take it with meals instead of 30 minutes before. More detailed product description
Aeskulap-Modified-Citrus-Pectin (AMCP) contains fractionated, heat- and pH modified pectin, a complex polysaccharide obtained from the peel and pulp of citrus fruits. AMCP is rich in galactoside residues, in particular β-galactose, known to have strong affinity for certain types of cancer cells.
The galactoside-containing carbohydrate side chains of AMCP can mimic or compete with natural ligand(s) of the so called tumor galactoside-binding protein, galectin-3, found on cancer cells, affecting cellular interactions relevant for metastasis.
AMCP also exerts immune stimulating effects in humans, increasing the activities of cytotoxic T cells, B cells and NK cells.
In search of naturally occurring substances useful in the treatment of cancer metastasis, modified citrus pectin (MCP) has emerged as a promising anti-metastatic drug candidate. MCP has been found to be effective in vitro and in vivo against various cancer entities, such as prostate- and breast carcinoma, melanoma, colon carcinoma, multiple myeloma, and hemangiosarcoma. More detailed product description
Aeskulap-Sitosterol-Mix produced by Aeskulap-International AG’s compounding contract pharmacy in Switzerland. This phytotherapy drug is individually prescribed for each patient and manufactured as so-called “Magistral-Rezeptur” (prescription magistralis) for the treatment of prostate cancer.
Our doctors and researchers have tested this product both in the laboratory and clinically. We will gladly provide you with the results of these independent tests upon request.
The most significant results follow here in brief:
Aeskulap-Sitosterol-Mix contains only components as prescribed by a physician.
Aeskulap-Sitosterol-Mix can be used in conjunction with conventional treatments for prostate cancer, for example, in the perioperative setting with radical prostatectomy or prior, during and after radiation treatment and chemotherapy.
Aeskulap-Sitosterol-Mix is an integral part of our treatment program for treatment of prostate cancer, even in the so-called castration resistant stage.
Aeskulap-Sitosterol-Mix is used in combination with ProstaSol, Curcumin combi extra forte, IMUPROS, and BIOBRAN by doctors within our network to treat prostate cancer of all stages, in particular also metastatic and castration-resistant variants of the disease.
Aeskulap-Sitosterol-Mix, used at the prescribed dosage, is usually well tolerated. Neverthe-less, about 25-30% of treated patients may notice some breast nipple soreness and slight breast enlargement, with treatment. Impairment of libido and erectile function and some stool softening has also been reported. All side effects are reversible upon dose reduction and discontinuation of treatment.
Although there are no so-called placebo-controlled, double-blind studies for this product and its application in the treatment of patients with prostate cancer, there are well-founded pre-clinical studies, as well as two retrospective clinical studies evaluating the effectiveness of Aeskulap-Sitosterol-Mix in prostate cancer.
If you decide to include Aeskulap-Sitosterol-Mix as a complementary oncological treatment, you should inform your doctor. You may also take advantage of our Aeskulap Patient Care Service and consult our expert doctors with any special medicinal questions you might have.
Whatever you decide, we wish you much success with your treatment and all the best!
Aeskulap-CA-Statin (ACAS) contains a proprietary extract of the common bindweed (Convolvulus arvensis), comprised of various proteoglycan molecules in combination with proprietary extracts from the following three medicinal plants: Corydalis rhizome (Corydalis yanhusuo), Lycoris radiata and Patrinia heterophylla. Aeskulap-CA-Statin significantly inhibits the growth of abnormal cells and new blood vessels (angiogenesis), necessary for cancer growth. It also has a distinct immune-stimulatory effect.
Since Dr. Folkman hypothesized that controlling angiogenesis could be a feasible anti-tumor strategy, clinical oncology has seen an ever growing interest in angiogenesis inhibitors as anti-tumor agents. Because of anecdotal reports of clinical benefit for cancer patients after consumption of extracts from common bindweed (Convolvulus arvensis) by researchers from AIDAN Corporation, USA – we started to test various extracts of this plant for their anti-angiogenesis and immune stimulating effects. From 2001 until 2012, we continued to improve the extract process and combined the Convolvulus arvensis extract with extracts from Corydalis rhizome (Corydalis yanhusuo), Lycoris radiata and Patrinia heterophylla, which resulted in an even better efficacy.
The initial work of the AIDAN research team is best summarized in the following article, which describes the biological properties of the Convolvulus arvensis extract, as well as its clinical potential and possible side effect profile. Read more detailed product description
Artemisinin™ is an extract of Artemisia annua, a plant that is also called Chinese Wormwood. Artemisinin was discovered as the active component of Artemisia annua in the early 1970s, and the leaf flavonoids from this plant, contained in many traditional Chinese herbal preparations, have shown a wide variety of biological activities against malaria and cancer.
In the Netherlands, Artemisinin is prepared as food supplement; however, the manufacturing process follows international standards for the production of pharmaceuticals.
Artemisinin is frequently used by patients with parasitic infections; in particular Malaria. The anti-Malaria efficacy of artemisinin has been recognized by the WHO and is reflected in the recommended use of artemisinin and its semi-synthetic analogs, such as dihydroartemisinin, artemether, arteether, and artesunate for otherwise treatment-resistant strains of Malaria. In the last decade, however, more and more scientific work has shown that artemisinin exerts also very potent anti-cancer effects. Today, many cancer patients utilize artemisinin in combination with their conventional therapy for added benefit in their fight against cancer. Read more detailed product description